by NanoVation | Mar 30, 2023 | Extrahepatic, Tissue, tumour
Adminstration route: i.v. Platform technology: lcLNP™ Modality: DNA Indication: not disclosed Strategy:...
by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, spleen, Tissue
Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA Indication: not disclosed Strategy:...
by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, Tissue
Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA/gRNA Indication: not disclosed Strategy:...
by NanoVation | Mar 30, 2023 | Blood/immune cells, Extrahepatic, Tissue, virus
Adminstration route: i.m. Platform technology: combined Modality: mRNA Indication: SARS & ASF Strategy:...
by NanoVation | Mar 30, 2023 | Extrahepatic, skin, Tissue
Adminstration route: i.v. Platform technology: lcLNP™ Modality: siRNA Indication: not disclosed Strategy:...